Clinical Trial Update: Comparison of 7-day and 14-day Bismuth Based Quadruple Therapy for Secondary Helicobacter Pylori Eradication [Phase 4]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 4 study comparing 7-day versus 14-day bismuth-based quadruple therapy for secondary Helicobacter py…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Bismuth subsalicylate (bismuth subsalicylate)
• METRONIDAZOLE (Metronidazole)
• Omeprazole (Omeprazole)
• tetracycline (tetracycline)

Snippet

Sponsor: Asan Medical Center | Conditions: Helicobacter Infection | Phase 4 | Status: COMPLETED